Results 71 to 80 of about 564,426 (377)

Detection and Genotyping of Epstein-Bar Virus Among Paraffin Embedded Tissues of Hodgkin and Non-Hodgkin's Lymphoma Patients in Ahvaz, Iran

Acta Medica Iranica, 2018
Epstein-Barr virus (EBV) is a DNA virus which belongs to the Herpesviridae family, has been infected with 90% of the world’s population. EBV is transmitted through saliva and associated with different diseases such as Infectious Mononucleosis ...
Ala Habibian, Manoochehr Makvandi, Alireza Samarbaf-Zadeh, Niloofar Neisi, Rahim Soleimani-Jelodar, Kamyar Makvandi, Shima Izadi   +6 more
doaj  

Phosphorylation‐Dependent Stabilization of Collaborator of ARF (CARF) Suppresses Lymphoma Cell Proliferation

Advanced Science, EarlyView.
This study revealed that oncogene Collaborator of ARF (CARF) is closely related to B‐cell lymphoma tumorigenesis, and shares a conserved mechanism regulating protein stability with Arabidopsis Kip‐Related Protein6 (KRP6) through casein kinase 1‐mediated phosphorylation. Reduced phosphorylation led to the enhanced protein stability of CARF, resulting in
Li Qu, Zhuang Wei, Shuting Zhou, Xiaofan Zhang, Wenjun Zhang, Aibin Liang, Zhe Wang, Hongwei Xue   +7 more
wiley   +1 more source

Association of group erythrocyte antigens and B-cell non-Hodgkin lymphoma

Regulatory Mechanisms in Biosystems, 2016
We analyzed the frequency distribution of blood groups AB0, Rhesus and Kell in patients with B-cell non-Hodgkin lymphoma. An increase of D− patients (31.0%) among ill in comparison to healthy individuals (16.5%) was found.
U. V. Tymoshenko, S. O. Sivkovych, K. G. Garkava, R. P. Pavlyuk, G. A. Myronenko   +4 more
doaj   +1 more source

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. [PDF]

, 2016
The objective of this study was to explore the cancer incidence rates among HIV-infected persons with commercial insurance who were on antiretroviral therapy and compare them with those rates in the general population. Paid health insurance claims for 63,
Ambinder, Richard F, Casper, Corey, Dhakal, Ishwori, Haigentz, Missak, Krown, Susan E, Lee, Jeannette Y, Mitsuyasu, Ronald T, Noy, Ariela, Palefsky, Joel M   +8 more
core   +3 more sources

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

New England Journal of Medicine, 2018
Copyright © 2017 Massachusetts Medical Society. BACKGROUND Brentuximab vedotin is an anti-CD30 antibody–drug conjugate that has been approved for relapsed and refractory Hodgkin’s lymphoma.
J. Connors, W. Jurczak, D. Straus, S. Ansell, W. Kim, A. Gallamini, A. Younes, S. Alekseev, Á. Illés, M. Picardi, E. Lech-Maranda, Y. Oki, T. Feldman, P. Smolewski, K. Savage, N. Bartlett, J. Walewski, R. Chen, R. Ramchandren, P. Zinzani, D. Cunningham, A. Rosta, N. Josephson, E. Song, J. Sachs, R. Liu, H. Jolin, D. Huebner, J. Radford   +28 more
semanticscholar   +1 more source

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, EarlyView.
ABSTRACT Disease Overview Primary cutaneous lymphomas are a rare and heterogeneous group of extranodal lymphomas that require the integration of clinical and histopathologic data for classification and treatment. Diagnosis Diagnosis and disease classification is based on histopathologic review and immunohistochemical staining of an appropriate skin ...
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox   +2 more
wiley   +1 more source

Pulmonalis eltérések Hodgkin-lymphomában [PDF]

, 2016
Absztrakt A Hodgkin-lymphoma kezelése a hematológia sikertörténetei közé tartozik. A korszerű kombinált kemo- és radioterápiának köszönhetően a betegek jelentős része túlél, így előtérbe ...
Illés, Árpád, Jóna Ádám (1985-) (orvos), Jóna, Ádám, Miltényi, Zsófia, Szemes, Katalin   +4 more
core   +1 more source

Hodgkin's lymphoma in adults

The Lancet, 2012
Management of Hodgkin's lymphoma continues to develop. Outcomes for patients with favourable-risk, early-stage disease are excellent, and serial reductions in intensity of treatment have been made to retain the excellent prognosis while reducing the late effects of treatment. Prognosis is also very good in advanced-stage disease but the rate of relapse
David C. Linch, William Townsend
openaire   +2 more sources

Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells.

Cancer Discovery, 2017
Patients with otherwise treatment-resistant Hodgkin lymphoma could benefit from chimeric antigen receptor T-cell (CART) therapy. However, Hodgkin lymphoma lacks CD19 and contains a highly immunosuppressive tumor microenvironment (TME).
M. Ruella, M. Klichinsky, S. Kenderian, O. Shestova, A. Ziober, Daniel O Kraft, M. Feldman, M. Wasik, C. June, S. Gill   +9 more
semanticscholar   +1 more source

Autoimmune Hepatobiliary Disease and Cryoglobulins in Peripheral Blood

American Journal of Hematology, EarlyView.
Cryoglobulins in Autoimmune Hepatobiliary Disease.
Anna Shestakova, Anton V. Rets, Madhu Menon   +2 more
wiley   +1 more source